← Open Payments lookup

AMANDA AYDIN: Open Payments

NPI 1821363144 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$339 in 17 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $46 · 2025 $339

Food & beverage: $339
CompanyPaymentsAmount
PFIZER INC.2$52
Astellas Pharma US Inc2$42
ABBVIE INC.2$41
Boehringer Ingelheim Pharmaceuticals, Inc.2$39
Sumitomo Pharma America, Inc.1$25
Merck Sharp & Dohme LLC1$23
Otsuka America Pharmaceutical, Inc.1$23
Lundbeck LLC1$20
TOLMAR, INC.1$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: REXULTI, Veozah, UBRELVY, JARDIANCE, NURTEC ODT, GEMTESA, GARDASIL 9, PAXLOVID.

Industry payments across NV — which companies pay providers there.